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Introduction
In mammals, adult neurogenesis was demonstrated to be active
in two main brain regions, namely the subventricular zone
(SVZ) and the dentate gyrus of the hippocampus, where neural
stem cells (NSCs) were isolated (Alvarez-Buylla and Garcia-
Verdugo, 2002; Galli et al., 2003). NSCs are characterized by
plasticity and multipotency so that they may proliferate and/or
undergo differentiation into functional progeny according to
the environmental conditions (Bottai et al., 2003). These
features make them ideal candidate targets for the cure of
neurodegenerative diseases, although the molecular
mechanisms that determine a NSC to proliferate or to
differentiate towards a neuronal or astroglial fate are only
partially elucidated (Qian et al., 2000; Roegiers and Jan, 2004).
Post-transcriptional regulation, exerted by RNA-binding
proteins (RBPs) as an alternative mechanism to the activity of
transcription factors in modulating gene expression, has
recently been shown to have a role in the development of the
central nervous system (CNS) and, in particular, in the control
of the NSC division mode (Okano et al., 2002). Several neural-
specific RBPs have been described so far to affect splicing,
transport, translation and stability of target mRNAs, and can
cause severe neurological disorders when altered (Perrone-
Bizzozero and Bolognani, 2002).
The Musashi-1 (Msi1) RBP was first reported to be required
for the proper development of the neural sensory organ in
Drosophila (Nakamura et al., 1994), whereas in mammals it is
commonly considered a specific marker for stem/progenitor
cells of neural origin (Kaneko et al., 2000; Maslov et al., 2004).
Msi1 acts as a translational suppressor by binding to the 3-
untranslated region (3UTR) of specific mRNA targets. In this
way the proliferation state of NSCs is maintained by inhibiting
the translation of the membrane protein Numb, involved in the
Notch/Delta signaling cascade (Imai et al., 2001), and of the
cyclin-dependent kinase inhibitor p21WAF-1 (Battelli et al.,
2006).
The neuronal-specific ELAV (nELAV) RBPs, which are
associated with the pathological condition of paraneoplastic
encephalomyelitis (Szabo et al., 1991), are necessary and
sufficient to induce neuronal differentiation in mammalian
cells (Akamatsu et al., 1999; Kasashima et al., 1999), as is their
elav ortholog in Drosophila (Robinow and White, 1991). The
three mammalian nELAV family members, HuB, HuC and
HuD, are commonly referred to as early and specific markers
Post-transcriptional regulation exerted by neural-specific
RNA-binding proteins plays a pivotal role in the
development and maintenance of the nervous system.
Neural ELAV proteins are key inducers of neuronal
differentiation through the stabilization and/or
translational enhancement of target transcripts bearing the
AU-rich elements (AREs), whereas Musashi-1 maintains
the stem cell proliferation state by acting as a translational
repressor. Since the gene encoding Musashi-1 (Msi1)
contains a conserved ARE in its 3 untranslated region, we
focused on the possibility of a mechanistic relationship
between ELAV proteins and Musashi-1 in cell fate
commitment. Colocalization of neural ELAV proteins with
Musashi-1 clearly shows that ELAV proteins are expressed
at early stages of neural commitment, whereas interaction
studies demonstrate that neural ELAV proteins exert an
ARE-dependent binding activity on the Msi1 mRNA. This
binding activity has functional effects, since the ELAV
protein family member HuD is able to stabilize the Msi1
ARE-containing mRNA in a sequence-dependent way in a
deadenylation/degradation assay. Furthermore activation
of the neural ELAV proteins by phorbol esters in human
SH-SY5Y cells is associated with an increase of Musashi-1
protein content in the cytoskeleton. We propose that ELAV
RNA-binding proteins exert an important post-
transcriptional control on Musashi-1 expression in the
transition from proliferation to neural differentiation of
stem/progenitor cells.
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of post-mitotic neurons during CNS development (Barami et
al., 1995; Okano and Darnell, 1997; Wakamatsu and Weston,
1997), whereas the fourth member, HuR, is ubiquitously
expressed. The ELAV RNA-binding activity promotes the
stabilization and/or translation of an array of transcripts
containing the AU-rich consensus element (ARE) in their
3UTR (Antic and Keene, 1997). ARE sequences represent
well-documented cis-acting regulatory motifs usually
identified in mRNAs of genes with a high turnover rate (Shaw
and Kamen, 1986), and are recognized by several ARE-binding
proteins which exert a different and often opposite role on
mRNA fate (Bevilacqua et al., 2003). nELAV target genes are
endowed with a wide variety of biological functions (Gao et
al., 1994), from cell growth regulation (Levine et al., 1993) to
brain maturation and maintenance (Antic et al., 1999; Aranda-
Abreu et al., 1999; Chung et al., 1997).
The expression of Msi1 and nELAV RBPs has been initially
described to be spatiotemporally sequential during the
development of murine CNS (Sakakibara et al., 1996),
although recent data suggest that nELAV proteins might have
an important role as early as the neuronal-specific commitment
of NSCs (Akamatsu et al., 2005).
In the present work we show that nELAV proteins are
expressed and colocalize with Msi1 in the adult mouse SVZ
and in cultured NSCs/progenitors, where they show a specific
and ARE-dependent binding activity for the Msi1 transcript. In
particular, we find that nELAV RBPs exert a stabilizing activity
on Msi1 mRNA decreasing its turnover rate in vitro and
promoting its translation in vivo. Such findings suggest a
mechanistic correlation between nELAV and Msi1 RBPs in
controlling the proliferation/differentiation activities of neural
stem/progenitor cells.
Results
The mammalian Msi1 3UTR contains a conserved AU-
rich element which is bound by multiple RBPs including
the nELAV proteins
Examination of the mouse Msi1 gene revealed the presence of
a putative ARE consensus sequence in its 3UTR, catalogued
as belonging to group III in the ARE-mRNA database (ARED)
(Bakheet et al., 2001). Since AREs are cis-acting regulatory
sites, they are usually well conserved throughout phylogenesis
(Asson-Batres et al., 1994), and indeed a comparative analysis
of Msi1 3UTRs in ortholog genes revealed that the human
sequence showed a 75% identity with its murine counterpart
(Fig. 1A). The EST-expanded rat Msi1 3UTR displayed the
same degree of conservation (74%), and alignment of the three
sequences gave almost full identity of a region of 24 bp,
including the putative functional ARE. On the other hand,
Danio rerio, Xenopus laevis, Caenorhabditis elegans and
Drosophila melanogaster Msi1 orthologs neither contained the
ARE signature nor showed any significant homology along the
entire 3UTR region. Also Msi2 gene, the ubiquitously
expressed member of the Musashi family (Sakakibara et al.,
2001), didn’t show any ARE consensus sequence in its 3UTR.
Therefore, we hypothesized that the ARE sequence present in
the Msi1 gene could have a role in influencing its mRNA
stability and in the post-transcriptional regulation of its
expression only in mammals. Prediction of the mouse Msi1
3UTR secondary structure by the Sfold RNA-folding
algorithm (Ding et al., 2004) clearly showed that the ARE
sequence is exposed in a single-stranded loop, which is likely
to be accessible to ARE-binding proteins (Fig. 1B).
In order to investigate the putative RNA-binding activities
associated with the Msi1 transcript, we performed
RNA/protein UV crosslinking experiments in the presence of
radiolabeled Msi1 3UTR riboprobe and protein extracts from
both mouse brain and cultured NSCs. After UV irradiation, the
resulting mRNA-protein (mRNP) complexes were separated
by SDS-PAGE and the electrophoretic pattern was compared
with that obtained for the growth-associated protein 43
(Gap43), a well-known mRNA target of the nELAV RBPs. A
partially overlapping profile was evident with common bands
of approximately 95, 65 and 42 kDa (Fig. 1C), the latter being
previously shown to correspond to the RNA-binding activity
of HuD (Chung et al., 1997). We observed two additional
mRNP complexes specific to the Msi1 3UTR, with apparent
molecular weights of 37 and 32 kDa, the lower band being
more abundant in NSCs and the upper one in whole brain
lysate.
These preliminary findings prompted us to investigate the
possible role of the nELAV RBPs as trans-acting factors in the
binding and regulation of the Msi1 transcript. To this purpose
after UV crosslinking assays, the resulting mRNP complexes
were immunoprecipitated with the pan anti-nELAV antibody
(16A11), which is known to recognize the three neuronal RBPs
HuB, HuC and HuD, but not HuR (Marusich et al., 1994) (Fig.
1D). A 42 kDa complex was immunoprecipitated in the
presence of the Msi1 3UTR riboprobe, confirming the
existence of an nELAV RNA-binding activity for the Msi1
transcript both in mature brain and in NSCs.
As several RBPs are reported to bind to their own mRNA
(Chu et al., 1991; Schaeffer et al., 2001), including nELAV
proteins (Abe et al., 1996; Samson, 1998), we also
immunoprecipitated the products of the UV crosslinking
reaction using the anti-Msi1 antibody, but the Msi1 transcript
was not recovered (Fig. 1E).
nELAV proteins are expressed in neural stem/progenitor
cells in vitro
Our preliminary data suggest the existence of a functional
correlation between the Msi1 gene, associated with the
maintenance of NSC proliferation, and the nELAV RBPs,
usually considered early markers of newly generated neurons.
NSCs isolated from developing or mature brain can be grown
in vitro as floating cell aggregates denominated neurospheres,
which are characterized by an indefinite proliferation
potentiality and by the multipotency to differentiate into the
principal neural phenotypes (Morshead and van der Kooy,
2004). We therefore looked for nELAV protein expression in
neurospheres obtained from adult mouse brains.
Immunolabeling images with the anti-Msi1 antibody showed
colocalization with the nELAV antigens throughout the sphere
(Fig. 2A-C), suggesting a stem identity of nELAV-positive
cells. To further characterize the expression of these RBPs,
from tridimensional neurospheres we obtained a monolayer of
stem/progenitor cells after dissociation and exposure to
adhesive substrate for 1 hour. This limited period of time
allows the preservation of the typical NSC heterogeneous
morphologies and it is not sufficient to commit cells towards a
specific fate (Bez et al., 2003; Suslov et al., 2002). As in
neurosphere cultures, double fluorescent signals for nELAV
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and Msi1 were still present although their cellular distribution
appeared slightly different, Msi1 signals being prevalent in the
nuclei and nELAV RBP signals more diffuse in the cytoplasm
(Fig. 2D-F). Coexpression of the intermediate filament nestin,
widely used as a neural stem/progenitor cell marker (Wiese et
al., 2004), with both nELAV and Msi1 demonstrated the still
undifferentiated and proliferating state of our neurosphere-
derived cell culture (data not shown). The specificity of the
anti-Msi1 antibody used was previously verified in committed
progenitor cells with neuronal morphology, which resulted
positive for the differentiation marker -tubulinIII and negative
for Msi1, and in immature astrocytes, positive for both GFAP
and Msi1 (Sakakibara et al., 1996) (data not shown).
Furthermore, the uncommitted mitotic state of the
neurosphere-derived cells was attested by the positive labeling
for the proliferation-associated antigen Ki67, a protein
produced in all active phases of the cell cycle, but absent in G0
(Kee et al., 2002). nELAV RBPs and Ki67 were co-expressed
Journal of Cell Science 119 (7)
in actively proliferating cells with a distinct cellular
distribution, nuclear for Ki67 and mainly cytoplasmic for
nELAV proteins (Fig. 2G-I). nELAV protein staining was also
present in non-proliferating Ki67-negative cells.
nELAV RBPs are expressed in the neurogenic SVZ in
vivo
Since our immunostaining data clearly indicate that nELAV
proteins are not limited to early post-mitotic and mature
neurons, we wanted to investigate nELAV expression in vivo
in the SVZ region, one of the germinal areas where
neurogenesis occurs in the adult. Brain sections from adult rats
were immunolabeled with anti-nELAV and anti-Ki67
antibodies (Fig. 3A,B): nELAV proteins were clearly expressed
in the SVZ and overlapped the Ki67 fluorescent signals with a
complementary intracellular distribution pattern (Fig. 3C,D).
As neuronal-specific markers, nELAV proteins were also
strongly expressed in the cerebral areas surrounding the lateral
Fig. 1. Computational analysis of the Msi1 3UTR sequence and identification of the associated RBP activities. (A) Alignment of the
mammalian Msi1 3UTR sequences is shown: Homo sapiens (Hs, NM_002442) at the top, Rattus norvegicus (Rn, CD568097) in the middle
and Mus musculus (Mm, NM_008629) at the bottom. Conserved nucleotides are highlighted in grey, whereas the ARE is indicated by the box.
(B) The most stable RNA secondary structure of the mouse Msi1 3UTR as predicted by the Sfold software (www.bioinfo.rpi.edu). The
magnification shows the loop exposing the ARE sequence, indicated by the arrow. (C) UV crosslinking assay of Msi1 and Gap43 3UTR
riboprobes and lysates from whole mouse brain and NSCs. The 95 kDa complex is detected only when brain extracts were used. The 37 and 32
kDa RNA-binding activities specific for Msi1 sequence are indicated by asterisks. (D) Immunoprecipitation of Msi1 and Gap43 riboprobes with
the anti-nELAV antibody after UV irradiation on brain and NSC extracts. A 42 kDa complex (arrowhead) was precipitated in all samples.
(E) Immunoprecipitation of the NSC UV crosslinked mRNPs with the anti-nELAV and the anti-Msi1 antibodies, respectively.
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1445Regulation of Msi1 mRNA by the nELAV proteins
ventricle, where Ki67 labeling was absent. Immunostaining
with the anti-Msi1 antibody confirmed the presence of
stem/progenitor cells in the SVZ. The concomitant expression
of Msi1 and nELAV proteins in this neurogenic region (Fig.
3E-G), mainly confined to the sub-ependymal cell layer (Fig.
3H), suggests the importance of both these RBPS in regulating
NSC proliferation.
The Msi1 mRNA is a target of the nELAV proteins in
neurospheres
We have found that nELAV proteins are endowed with an
RNA-binding activity for the Msi1 transcript and are expressed
in neural stem/progenitor cells in vitro and in vivo. A
ribonomic approach (Tenenbaum et al., 2002) was then used
to isolate nELAV-containing mRNP complexes from adult
mouse neurospheres. Endogenous mRNPs were
immunoprecipitated from neurosphere lysates with anti-
nELAV, with an irrelevant isotype-matched antibody (anti-
His5) and with no antibody, respectively, in three independent
experiments. Precipitated mRNAs from each sample were
subjected to quantitative real-time RT-PCR using specific sets
of primers for Msi1, Rpl10a, Gap43 and Mapt (microtubule-
associated protein tau) genes. The housekeeping Rpl10a,
encoding a ribosomal large subunit protein, was used as
negative control because it does not contain an ARE consensus
sequence in its 3UTR. Gap43 and Mapt are two well-known
mRNA targets of nELAV RBPs both in developing and mature
neurons. In the nELAV-containing mRNP complexes, Msi1
mRNA was enriched 62-fold compared with the control sample
(anti-His5) (Fig. 4), whereas Rpl10a was absent in all the
experimental conditions tested, although its content in the input
lysate was 100-fold more abundant than Msi1 (see Table S1 in
supplementary material). Neither Gap43 nor Mapt transcripts
were significantly immunoprecipitated from neurospheres by
the anti-nELAV antibody, even if these two genes were
expressed in the input lysate and were recovered from mRNPs
of mouse mature brain (data not shown).
We also immunoprecipitated the endogenous mRNP
complexes containing the Msi1 protein in order to test the
presence of the Msi1 transcript itself among its targets. No
significant results were found in line with the negative data
obtained in UV crosslinking assays and confirming the
observation that the Msi1 3UTR sequence does not show any
consensus binding site (G/AUnAGU) for Msi1 (Imai et al.,
2001).
The HuD protein shows an ARE-dependent binding
activity for the Msi1 3UTR
We then tested whether nELAV protein binding to Msi1
mRNA was dependent on the presence of the putative ARE
consensus sequence. Two deletion transcripts, ARE+ and
ARE–, were obtained from the mouse Msi1 3UTR sequence
(Fig. 5A), where the ARE+ fragment
encompassed the conserved ARE-
containing region we identified by
phylogenetic analysis. UV-
crosslinking assays on neurosphere
lysates revealed that the ARE+ probe
showed the same RBP-binding pattern
as the full-length Msi1 3UTR,
whereas all RNA-protein interactions
were abolished when the ARE–
fragment was used (Fig. 5B, left
panel). This finding suggests that the
presence of RBPs or associated
proteins in the Msi1-containing mRNP
complexes is strictly dependent on the
cis-acting regulatory sequence of the
ARE region. We have demonstrated
that nELAV proteins exhibit an RNA-
binding activity for the Msi1 transcript
both in in vitro and in vivo
immunoprecipitation assays. In order
to further characterize this binding
affinity, we expressed a recombinant
His-tagged HuD protein and
performed UV-crosslinking
experiments. RNA-protein complexes
formed with the Msi1 full-length
3UTR and ARE+, but not with the
ARE– riboprobe, confirming a strictly
ARE-dependent binding activity of
the HuD protein (Fig. 5B, right panel).
To demonstrate the specificity of such
in vitro binding, competition assays
were performed using a 100 molar
excess of ARE+ and ARE– riboprobes
Fig. 2. nELAV RBPs are expressed in neurospheres and neural stem/progenitor cells in vitro.
(A,B) The nELAV antibody (green) was used in combination with anti-Msi1 antibody (red) to
label adult mouse neurospheres showing a strong overlapping expression of the two RBPs in
the whole neurosphere (C, merged). (D,E) Colocalization of nELAV (green) and Msi1 (red)
RBPs is more evident in single stem/progenitor cells. Most of the neurosphere-derived
precursors show the expression of the two antigens with a different cellular distribution,
mainly nuclear for Msi1 (F, merged, arrow). The same field is represented in the inset at a
reduced size where nuclei are evidenced by DAPI counterstaining (arrow). (G,H,I) The
proliferative state of the cell culture is attested by nELAV (green) and Ki67 (red) positive
labeling. These two proteins are coexpressed in certain precursors, whereas nELAV is
selectively expressed in others (arrowheads). The nuclear localization of Ki67 antigen is
clearly visible (asterisks). Bars, 100 m (A-C); 25 m (D-I).
Jo
ur
n
a
l o
f C
el
l S
cie
nc
e
1446
together with Msi1 full-length 3UTR (Fig. 5C, left and right
panels). Although ARE– had no ability to bind to HuD, cold
ARE+ and Msi1 3UTR efficiently competed with the
radiolabeled probe. The HuD-specific binding to Msi1 ARE
sequence was also confirmed by the absence of interaction
with an irrelevant sequence (As). The binding was dose
dependent, as shown by UV-crosslinking assays performed
with increasing amounts of recombinant HuD protein (Fig.
5D).
HuD acts on the Msi1 mRNA by reducing its degradation
rate
ARE sequence elements are usually present in mRNAs with a
high turnover rate (Chen and Shyu, 1995), on which they
determine increased or decreased stability, probably depending
on the bound RBPs (Lal et al., 2004). We wanted to investigate
whether the presence of the HuD-bound ARE in the Msi1 gene
was associated to a cis-acting regulatory role. To this end, the
stability profile of the Msi1 mRNA was studied by means of a
functional approach which allowed us to reproduce and follow
the mRNA deadenylation/degradation kinetic profile in vitro
Journal of Cell Science 119 (7)
Fig. 3. nELAV proteins are
expressed in the proliferating cells
of the adult rat SVZ.
(A,B) Immunolabeling with anti-
nELAV (red) and anti-Ki67
(green) antibodies revealed
coexpression of the two markers
(C, merged, higher magnification
of the field indicated in B) in the
sub-ependymal layer of the adult
SVZ, where proliferating
stem/progenitor cells are present.
(D) A magnified image of the
region indicated in C (bracket)
clearly shows the distinct nuclear
and cytoplasmic distribution of the
Ki67 and nELAV markers,
respectively, in the same cells.
(E,F) nELAV (red) and Msi1
(green) RBPs colocalized in the
SVZ (G, merged, higher
magnification image of the field in
F) and presented the same
cytoplasmic distribution pattern
(H, magnified picture of the region
indicated in G by the bracket). Cc,
corpus callosus; ChP, choroid
plexus; CPu, caudate putamen; Lv,
lateral ventricle; RMS, rostral
migratory stream. Bars, 100 m
(A,B,E-F); 50 m (C,G); 25 m
(D,H).
Rpl10a Msi1 Gap43 Mapt
Fig. 4. Real-time PCR-based identification and quantification of
mRNAs associated to nELAV-mRNP complexes in adult
neurospheres. Endogenous mRNPs were immunoprecipitated by
anti-nELAV, anti-His5 and no antibody and the collected mRNA
species were quantified by real-time RT-PCR. The normalized fold
difference is indicated with respect to the sample where no antibody
was used (mean value ± s.e.m.; one-way ANOVA, n=3, ***P<0.001
for anti-nELAV antibody compared with both controls).
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(Ford et al., 1999). For this assay short capped and
polyadenylated (polyA60) transcripts were synthesized to
represent the putative functional region of the Msi1 3UTR. We
produced a 114 bp 32P-labeled fragment containing the ARE
consensus site (msi1ARE+) and an irrelevant 148 bp
transcript as a control (msi1AS, the antisense sequence of the
ARE– fragment). The deadenylation kinetic and the associated
degradation of the body of these two synthetic mRNAs,
composed only of putative regulatory sequences, were
followed by simply visualizing their decrease in length on a
denaturing gel. We observed that the deadenylation of the
msi1ARE+ transcript was progressive and became complete
within 30 minutes compared with the fully deadenylated probe
(A0), used as a reference marker (Fig. 6A). By contrast, high-
molecular-weight intermediates of the msi1AS probe (i.e.
smear length and consistence) were still present after a longer
incubation time (45 minutes), indicating a slower degradation
kinetic rate.
When the same deadenylation/degradation assay was
repeated in the presence of the recombinant HuD protein, the
decay rate of the msi1ARE+ transcript markedly decreased
compared with the control, and resembled that of the
msi1AS mRNA in the degradation profile (Fig. 6B). Indeed,
after a 45-minute incubation, the shortening of the polyA60 tail
was still incomplete compared with the same sample
incubated in the absence of HuD, with the persistence of high-
molecular-weight species corresponding to the almost intact
transcript. When the msi1AS mRNA was used, the addition
of the recombinant HuD protein did not alter the
deadenylation pattern (data not shown). These results
demonstrate that the conserved AU-rich region in the Msi1
3UTR acts as a cis-acting regulatory sequence on which the
nELAV HuD protein specifically exerts its stabilizing activity
by decreasing its mRNA turnover rate.
Fig. 5. HuD protein specifically recognizes and binds the Msi1
3UTR sequence. (A) Schematic representation of the mouse Msi1
3UTR (399 bp). ARE+ (230 bp) and ARE– (148 bp) deletion
segments were obtained by PCR amplification with the indicated
primer pairs (see Materials and Methods). (B) Left panel,
polyacrylamide gel of UV-crosslinking assays on neurosphere
extracts with the ARE+ and ARE– deletion segments. The binding
activity was completely abolished in the absence of the ARE
element. Msi1 full-length 3UTR was used as a positive control
(middle lane). Right panel, UV crosslinking assay of the recombinant
HuD protein with the Msi1 3UTR riboprobe compared with Gap43
as a control. The 42 kDa complex (arrowhead) can be detected. HuD
specifically bound the deletion fragment ARE+, but not the ARE–
sequence. (C) Left panel, competition experiments with the
recombinant HuD protein were performed with the addition of a
100 molar excess of cold ARE+ and ARE– riboprobes. The Msi1-
HuD complex is shown in the first lane before the addition of the
cold competitors. Right panel, an excess of cold full-length Msi1
3UTR completely inhibited the formation of the mRNP complex.
The antisense Msi1 sequence (As) was not able to specifically bind
HuD protein. (D) Dose-dependent binding-activity of the HuD
protein (0.1, 0.2, 0.4, 1 g) to the Msi1 3UTR sequence.
Fig. 6. The conserved ARE sequence affects Msi1 mRNA stability in
vitro. (A) Decay assay of msi1ARE+ and msi1AS radio-labeled
transcripts at different time points. The A60 labels represent the initial
msi1ARE+ andmsi1AS transcripts with 60 adenines in the polyA
tail, whereas the A0 labels represent the corresponding deadenylated
transcripts. (B) The deadenylation rate of the msi1ARE+ RNA
changed after the addition of 0.75 g of the HuD protein, with a
decay pattern similar to that of the msi1AS transcript. The
deadenylation/degradation profiles were highly reproducible
(compare the msi1ARE+ decay in A and B).
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The PKC-dependent activation of the nELAV RBPs
upregulates Msi1 translation in the cytoskeleton
We have recently shown that the nELAV proteins undergo
translocation from the cytosolic to the cytoskeletal
compartment after treatment with phorbol esters (PMA) in
human neuroblastoma SH-SY5Y cells (Pascale et al., 2005).
Such translocation is accompanied by nELAV RBP threonine
phosphorylation as a consequence of PKC isozyme
activation. A PKC-dependent stabilization of the Gap43
mRNA and an increase in its protein levels were also
specifically observed in the cytoskeleton. We investigated the
effect of nELAV protein activation on Msi1 content in the same
cell model after treatment with PMA or solvent alone (DMSO).
Msi1 protein levels were examined on cellular fractions by
western blotting (Fig. 7A). PKC translocation to the
cytoskeletal compartment was clearly evident (+63%, P<0.05),
together with nELAV protein increase (+98%, P<0.001),
reproducing the nELAV RBP activation process already
described. We also found that the Msi1 protein content
significantly increased in the cytoskeleton (+107%, P<0.001)
after nELAV RBP activation by phorbol ester treatment. 
Discussion
In this paper we reveal the existence of a post-transcriptional
regulatory mechanism involving Msi1 and HuD, two neural-
specific RNA-binding proteins implicated in the control of the
proliferation/differentiation switch during neuronal
development. Msi1 overexpression has been associated with
the proliferation state and degree of malignancy of brain
Journal of Cell Science 119 (7)
tumors such as gliomas (Kanemura et al., 2001; Toda et al.,
2001). As a consequence, we expect that Msi1 expression has
to be properly regulated both at transcriptional and
translational levels during the proliferation phases of neural
development. We focused on the presence of a putative ARE
consensus motif in Msi1 3UTR gene. The high degree of
conservation of the entire 3UTR sequence in only the
mammalian Msi1 orthologs strongly suggests a putative role in
a phylogenetically recent post-transcriptional regulatory
mechanism. In our UV-crosslinking experiments, we found
several RBPs showing a binding activity for the mouse Msi1
3UTR sequence in a strictly ARE-dependent manner, in a
pattern which partially overlaps the one previously described
for the Gap43 mRNA, a well-characterized target of the ELAV
protein family (Chung et al., 1997; Quattrone et al., 2001). By
this analogy, the common 65 kDa and 95 kDa bands could be
hypothesized to correspond to the RNA-binding activities of
PTB (pyrimidine-tract binding) and FBP (far-upstream-
element binding) proteins, respectively (Irwin et al., 1997;
Kohn et al., 1996), whereas here we demonstrate that the
common 42 kDa complex does indeed represent the HuD
protein. These different RBPs could play opposite roles on
mRNA fate, because they were shown to bind in a competitive
manner to the same cis-acting regulatory element in the Gap43
3UTR sequence (Irwin et al., 1997). Moreover, it is described
that the balance resulting from distinct RNA-binding activities
on different regulatory elements of the same transcript may
contribute to finely and gradually regulate the passage from
proliferation to differentiation programs (Briata et al., 2003;
Yano et al., 2005). More generally, a coordinated expression of
neural genes could be obtained by the association of their
mRNAs in common mRNP complexes (Keene, 2001),
composed of RBPs which are temporally specified.
From our work we have an indirect evidence that nELAV
activity could be developmentally regulated, because by
selectively immunoprecipitating nELAV-containing mRNP
complexes from adult neurospheres we were unable to show
any binding to two well-known mRNA targets, Gap43 and
Mapt, which nonetheless are expressed in proliferating
neurospheres (Esdar et al., 1999). Therefore, nELAV binding
to ARE-bearing mRNAs could depend on various factors like
nELAV activation and phosphorylation state (Pascale et al.,
2005), and on the interaction or competition with other RBPs
in a cell-state and cell-compartment specific manner.
Immunoprecipitation of neurosphere mRNPs and in vitro
binding experiments with the recombinant HuD protein clearly
demonstrated that nELAV proteins are able to recognize the
Msi1 transcript in an ARE-specific and ARE-dependent way.
We looked for a functional meaning of this association by the
approach described by Ford and Wilusz (Ford and Wilusz,
1999), a highly reproducible system that mimics the whole
mRNA catabolism in vitro. Results obtained by this
deadenylation and degradation assay showed that the basal
decay pattern of a synthetic mRNA bearing the Msi1 ARE
sequence was faster than in its absence, and that addition of
the recombinant HuD protein stabilized this transcript, as
similarly described for HuB and TNF- (Ford et al., 1999).
Therefore, the HuD activity on the Msi1 transcript suggests a
positive effect on its translation, as already described for other
nELAV target genes (Antic et al., 1999; Mazan-Mamczarz et
al., 2003). Our functional data on neuroblastoma cells showed
Fig. 7. nELAV-dependent upregulation of Msi1 protein after phorbol
ester treatment. (A) After stimulation for 15 minutes with 100 nM
PMA or DMSO, cell fractions (cytosol, membranes and
cytoskeleton) were separated from human SH-SY5Y cells. Samples
were analysed by western blotting with the indicated antibodies.
(B) Densitometric analyses of western blot data normalized to -
tubulin protein content (mean ± s.d.; n=3, *P<0.05, ***P<0.001,
Student’s t-test).
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that phorbol-ester-induced stimulation of diacylglycerol-
dependent PKC isozymes determines an increase of PKC and
nELAV protein content in the cytoskeleton. This effect,
previously described to be associated with PKC and nELAV
protein colocalization and with an increase in the threonine
phosphorylation state of nELAV RBPs (Pascale et al., 2005),
probably reflects an induction of nELAV activity at the
polysomal level (A.Q., unpublished results). We showed that
these phenomena were also associated with an increase in the
Msi1 protein content, which was evident especially in the
cytoskeletal compartment, as already shown for the nELAV
protein target GAP-43.
Immunolabeling studies in cultured NSCs and in the SVZ
of adult rat brains clearly showed that the nELAV RBPs are
expressed and colocalize with the Msi1 protein in neural
stem/progenitor cells, thus extending their biological role in
NSC fate determination. This observation is in agreement with
the recent description of the HuD-null mouse phenotype,
where a perturbation of the proliferation and differentiation
processes in neurospheres was observed (Akamatsu et al.,
2005). An overall distinct and complementary expression
pattern for Msi1 and nELAV RBPs has been previously
reported during rodent brain development (Kaneko et al., 2000;
Sakakibara et al., 1996; Sakakibara and Okano, 1997), which
correlates with the observation of opposite effects of thyroid
hormone on the transcription of the Msi1 and HuD genes
(Cuadrado et al., 2002; Cuadrado et al., 2003). However,
analyzing Msi1 and nELAV protein expression in neurogenic
regions, they were described to colocalize in vivo at the border
of the mouse embryonic subventricular and intermediate zones
(Sakakibara et al., 1996), and in differentiation-committed
areas including the anterior horn of the spinal cord.
Furthermore, their coexpression was also observed in vitro in
MAP2-positive cells from embryonic neuroepithelial cultures
(Kaneko et al., 2000).
Neurogenesis is a multi-step cell process that gradually leads
a self-renewing undifferentiated NSC to acquire a completely
differentiated phenotype. During embryogenesis this is
achieved through symmetric division of the initial NSC, which
increases the body mass as a first step. Progenitors, slightly
differentiated and committed cells, originate from NSCs by
sequential asymmetric division and, although for a limited
number of cell cycles, they maintain the proliferative capacity.
Therefore the cell programs of proliferation and differentiation
are both active in progenitors, and need to be finely co-
regulated. A molecular pathway known to be essential for the
maintenance of actively proliferating NSCs is the Notch/Delta
cascade, which controls cell division and neural differentiation
(Hitoshi et al., 2002). The Msi1 protein contributes to the
Notch-mediated proliferation of NSCs by binding and
preventing the translation of Numb (Imai et al., 2001), which
is known to negatively affect Notch activation (Cayouette and
Raff, 2002; Zhong et al., 1996). On the other hand, the nELAV
proteins have been widely demonstrated to be necessary and
sufficient to induce neuronal differentiation in vitro. The exact
timing and cascade of events that cause an NSC to completely
exit from the cell cycle is hard to define, but the process is
accompanied by the inactivation of cyclin-dependent kinases
by specific inhibitors, such as p21WAF-1. Interestingly, its
mRNA was shown to be regulated positively by HuD (Joseph
et al., 1998) which competes with hnRNP K for the same
3UTR motif (Yano et al., 2005), and negatively by Msi1
whose binding to an adjacent site blocks p21WAF-1 translation
(Battelli et al., 2006). According to our results, we propose that
the HuD-mediated stabilization of Msi1 mRNA may serve to
prolong Msi1 activity in the proliferating neural progenitor cell
which is going to exit the cell cycle (Fig. 8). This would allow
the stem/progenitor cell to continue to divide even after Msi1
transcriptional inactivation.
The post-transcriptional regulative mechanism of nELAV
proteins on Msi1 mRNA seems to be evolutionarily restricted
to mammals from embryonic to adult neurogenesis.
Regenerative events in the SVZ have already been
demonstrated to occur in vivo in the adult CNS after an
ischemic insult or a damage (Douen et al., 2004; Yagita et al.,
2002), whereas in the hippocampus, neurogenesis has been
strictly linked to the processes of learning, neuronal plasticity
and memory formation (Kempermann et al., 2004; Schinder
and Gage, 2004). Upregulation and cytoskeletal translocation
of nELAV proteins and the subsequent positive effects on
Gap43 mRNA levels have been recently described in tight
association with synaptic plasticity and learning processes in
rat dentate gyrus (Bolognani et al., 2004; Pascale et al., 2004;
Quattrone et al., 2001). We speculate that our findings of a
positive nELAV modulation of Msi1 transcript and protein
level could be required for the transition from proliferation to
differentiation of the stem/progenitor cells residing in the
hippocampal subgranular zone, as well as in the SVZ. In adult
Msi1 Gap43p21WAF MaptFig. 8. Model of the hypothetical role of
the nELAV RBPs during neurogenesis. In
the temporal sequence of events that lead
a proliferating NSC to become a
differentiated neuron, Msi1 and nELAV
RNA-binding activities are
complementary and exert a different
function on their target mRNAs. nELAV
stabilization of the Msi1 transcript may
prolong its expression during the gradual
passage from proliferation to
differentiation.
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neurogenic areas, nELAV activity could be assumed to be
transiently induced by signals present only in restricted spatial
and/or temporal conditions. We have recently demonstrated
that nELAV proteins are activated by a PKC-dependent
pathway in human neuroblastoma cells (Pascale et al., 2005),
and it is known that PKC-dependent signal transduction is at
the basis of many aspects of CNS development (Metzger and
Kapfhammer, 2003). The combination of these observations
with the present results could open the possibility of a
pharmacological modulation of NSC dynamics.
In conclusion, our results suggest that in mammals nELAV
proteins may have a key biological role in positively regulating
Msi1 gene expression along a molecular cascade leading a
proliferating stem cell towards a multi-step neural
differentiation process. Since the intrinsic features of NSCs
make them attractive candidates for cell-based repair therapy
of the CNS (Cova et al., 2004; Lakshmipathy and Verfaillie,
2005), the nELAV/Msi1 pathway could also represent a new
pharmacological target for enhancement of neurogenesis in the
treatment of neurodegenerative disorders.
Materials and Methods
Cell culture
Neural stem/progenitor cell cultures were obtained from CD1 mouse brains as
previously published (Gritti et al., 1999). After isolation of adult SVZ, tissue was
papain-digested and mechanically dissociated. Single cells were plated with a
density of 3.5103 cells/cm2 in NS-A basal serum-free medium (Euroclone),
supplemented with 20 ng/ml epidermal growth factor (EGF) and 10 ng/ml basic
fibroblast growth factor (bFGF, PeproTech) and optimized for stem-cell growth. In
7-10 days neurospheres were obtained, and every 5-7 days they were dissociated to
single cells for 3-5 passages in order to amplify the neural stem compartment. For
immunocytochemical assays, they were plated, as neurospheres or dissociated
stem/precursor cells, on an adhesive substrate (MatrigelTM, Becton Dickinson) for
1 hour.
Human neuroblastoma SH-SY5Y cells were grown in MEM (Eagle’s minimal
essential medium) with 10% fetal calf serum, penicillin/streptomycin, non-essential
amino acids and 1 mM sodium pyruvate (Invitrogen). Cells were exposed to 100
nM phorbol 12-myristate-13-acetate (PMA, Sigma) or to the solvent alone (DMSO)
for 15 minutes and then the incubation was stopped with ice-cold PBS.
Protein extracts, cell fractioning and western blot
Total mouse brain and NSC cultures were homogenized in lysis buffer (150 mM
NaCl, 20 mM Tris-HCl, 1% Triton X-100, protease inhibitor cocktail; Roche) and
400 U/ml RNase inhibitor (Promega). Samples were centrifuged at 12,000 g for 20
minutes at 4°C and supernatant was collected. Proteins from different cell fractions
were obtained as previously published with slight modifications (Pascale et al.,
1996). Briefly, SH-SY5Y cells were homogenized in buffer A (20 mM Tris-HCl pH
7.4, 2 mM EDTA, 0.5 mM EGTA, 50 mM mercaptoethanol, 0.32 mM sucrose and
protease inhibitor cocktail) and centrifuged at 100,000 g for 1 hour. The supernatant
containing the cytosolic fraction was collected. The pellet was resuspended in the
same buffer containing 1% Triton X-100, sonicated, and incubated for 45 minutes
at 4°C, then centrifuged again at 100,000 g for 1 hour. The supernatant containing
the membrane fraction and the pellet with the cytoskeletal component were
collected. Proteins were resolved by SDS-PAGE, transferred to nitrocellulose
membranes and immunoblotted with Msi1 (1:200, Chemicon), PKC (1:1000,
Transduction Laboratories), -tubulin (1:5000, Santa Cruz Biotechnology)
antibodies, and Hu-positive serum (1:1000).
Plasmid constructs
Total RNA was extracted from whole mouse brain with TriZol® reagent (Invitrogen)
and used to amplify Msi1 and Gap43 3UTR sequences by RT-PCR with the
following primers: Msi1_fw TGAGGACCAGACTGAGCCAGCAAG and
Msi1_rev GGGGCCTCAGTCTGCAGCAG; GAP-43_fw ATGCCTGAACTTT-
AAGAAATGGCT and GAP-43_rev ATGAGGAAACAAAATGGTTTTTG. The
products were cloned into pGem®-T Easy Vector (Promega). ARE+ and ARE–
fragments were obtained by PCR amplification of the above Msi1-pGem® construct
with the following primers: Msi1_fw and ARE+_rev GTAGGGCAA-
CTGGCTAATC; ARE–_fw GATTAGCCAGTTGCCCTAC and Msi1_rev. The
msi1ARE+ insert was subcloned from the Msi1-pGem® construct (primers:
CTCATGTCTGGCTCCCCTACT and GTAGGGCAACTGGCTAATC) into the
pCR®II-TOPO® (Invitrogen) vector and selected in order to have the T7 promoter
at the 5 end and the HindIII restriction site at the 3 end of the cloning site for the
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mRNA decay assay. The cDNA fragment encoding the open-reading frame for HuD
(GenBank accession number D31953) was amplified by RT-PCR using the
following modified primers: HuD_fw
TGATCTCATGAAGCCTCAGGTGTCAAATGGAC and HuD_rev CTG-
CATCCCGGGGGATTTGTGGGCTTTGTTGGTT. The product was digested with
RcaI/SmaI and directionally cloned into the expression vector pIVEX2.3d (Roche)
with a His tag at the C-terminus. All the clones and their orientation were validated
by sequencing.
RNA labeling
Radiolabeled riboprobes were obtained by transcribing 0.5 g linearized construct
DNA with 20 U T7 RNA polymerase (Roche), 20 Ci [-32P]UTP, 0.5 mM NTPs,
20 U RNase inhibitor (Promega) for 30 minutes at 37°C. The reaction was stopped
at 65°C and template DNA was removed by DNaseI digestion (20 U, Roche). The
resulting 32P-labeled riboprobe was purified on ProbeQuant G-50 microcolumns
(Amersham Biosciences).
In vitro Translation
Recombinant HuD protein was obtained in a cell-free system in which 0.5 g HuD-
pIVEX2.3d plasmid was incubated at 30°C for 6 hours in the reaction solution,
containing E. coli lysate and amino acids according to the manufacturer’s
instructions (Roche). The fusion protein was purified on Ni-NTA spin kit columns
and visualized by western blotting using an Anti-His5 antibody (Qiagen).
UV crosslinking and immunoprecipitation
300,000 cpm of 32P-labeled RNA transcripts were incubated with 40 g of protein
extract or with 300 ng of recombinant HuD protein in 15 l ligation buffer (1.3
mM MgCl2, 19 mM HEPES-KOH pH 7.4, 1.5 mM ATP, 19 mM creatine
phosphate) for 10 minutes at 30°C. After addition of 5 g tRNA, samples were
irradiated with UV (Stratalinker®, Stratagene) for 5 minutes on ice and RNaseA
treated (25 U) for 30 minutes. Samples were run on a 12% SDS-PAGE, and
analyzed by autoradiography. For competition experiments, a 100 molar excess
of cold riboprobe was added to the sample before UV irradiation.
Immunoprecipitation was conducted on UV crosslinked samples by the addition
of 4 g of the selected antibody for 2 hours at 4°C. Samples were then incubated
with 30 l Protein A/G Sepharose beads (Amersham Biosciences) for 2 hours at
4°C. Immunocomplexes were then collected by centrifugation at 14,000 g for 30
seconds, washed several times in lysis buffer, run on a 12% SDS-PAGE and
analyzed by autoradiography.
Immunocytochemistry and immunohistochemistry
Cells were fixed with 4% paraformaldehyde in PBS (pH 7.4) for 20 minutes,
blocked with 10% normal goat serum (NGS) and permeabilized with 0.3% Triton
X-100 (Gritti et al., 1999). 20-m-thick coronal brain sections from adult rats
intracardially perfused with 4% paraformaldehyde were mounted on glasses pre-
coated with poly-L-lysine. Sections were boiled for 15 minutes in 50 mM Tris-HCl
(pH 8.0), permeabilized with 0.5% Triton X-100 and blocked with 10% NGS.
Samples were exposed to the selected antibodies overnight at 4°C (antibodies and
dilutions used are specified in Table S2 in supplementary material). Slides were
mounted with FluorsaveTM (Calbiochem) and acquired with a camera connected to
a DMIRE2/HCS microscope (Leica Microsystems). For negative controls, the
primary antibody was replaced with NGS.
Isolation and immunoprecipitation of mRNP complexes
About 5106 NSCs were harvested for each condition, washed several times with
cold PBS and resuspended in 1:1 (v/v) RNP buffer (100 mM KCl, 5 mM MgCl2,
10 mM HEPES pH 7.4, 0.5% NP-40) (Tenenbaum et al., 2002). 50 l protein A/G
Sepharose beads, pre-coated with 8 g of the selected antibody, were added to 300
g NSC lysate in 1 ml NT2 buffer (50 mM Tris-HCl pH 7.4, 150 mM NaCl, 1 mM
MgCl2, 0.05% NP-40), containing 400 U RNase inhibitor, 1 M DTT and 20 mM
EDTA. 10% of the reaction mix was collected as the initial input and RNA was
extracted by TriZol® reagent (Invitrogen). After a 2-hour incubation, the
immunoprecipitated mRNPs were washed several times with cold NT2 buffer,
incubated with 30 g of proteinase K for 30 minutes and phenol-chloroform
extracted. After DNaseI digestion, the isolated mRNAs were retro-transcribed using
SuperScriptII RT (Invitrogen), oligo dT and random primers.
Real-time quantitative PCR
Real-time PCR was performed for 45 cycles with SYBRGreen PCR Master mix
(Applied Biosystems) and processed on the ABI Prism 7900HT sequence detection
system. Oligonucleotide pairs for each gene were designed with Primer Express 2.0
software (Applied Biosystems) on exon boundaries. Reactions were conducted in
triplicate for each sample and a dissociation curve was produced at the end. For the
mRNP assays, the threshold cycle (Ct) values of immunoprecipitated samples were
normalized to the Ct value of the corresponding input (Ct) to account for
differences in initial mRNA quantities. Ct was calculated by subtracting the Ct
value of the sample with no antibody to the Ct of the sample with anti-nELAV or
anti-His5 antibodies and fold differences were then expressed as 2-Ct (Chakrabarti
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et al., 2002). Statistical analysis was conducted by one-way ANOVA with
Bonferroni t-test correction. For primer sequences and real-time PCR data see
Tables S1 and S3 in supplementary material.
In vitro mRNA degradation/deadenylation assay
The mRNA decay experiments were conducted as described (Ford and Wilusz,
1999) with some modifications. Whole-brain cytoplasmic extracts were used to
reproduce a neural-like environment in vitro. The addition of the polyA60 tail to the
msi1ARE+ or msi1AS constructs was carried out by the PCR-ligation procedure.
Briefly, the double-stranded linker AGCTT(A)60TATTTACCTCGAGCACTC was
ligated to the HindIII-digested plasmids, which were then amplified with the T7
promoter primer and the complementary linker primer (GAGTGCTCGAG-
GTAAATAT). Products were digested with SspI and in-vitro transcribed in the
presence of 7mGpppG (Roche) and [-32P]UTP. Riboprobes were run on a
denaturing 5% polyacrylamide gel (19:1) containing 8 M urea. After a short
autoradiographic exposure, bands were excized from the gel, eluted overnight in
HSCB buffer (400 mM NaCl, 25 mM Tris-HCl pH 7.6, 0.1% SDS), phenol-
chloroform extracted and ethanol precipitated. 200,000 cpm riboprobes were
incubated with 200 g of mouse brain extract and 0.5 g polyA (Amersham
Biosciences) in 15 l deadenylation buffer (2.6% polyvinyl alcohol, 1 mM ATP, 13
mM creatine phosphate) at 30°C. At the indicated time intervals reactions were
stopped with 400 l HSCB buffer. RNA was extracted in phenol-chloroform,
separated on an urea-denatured 5% polyacrylamide gel and visualized by
autoradiography.
We thank C. Fenoglio, A. Grifa and M. G. Savino for their kind
help. This work was supported by Italian Ministry of Health (Mal.
Neurodegenerative, ex art.56 Anno 2003), Fondazione I.Monzino and
Fondazione FiorGen.
References
Abe, R., Sakashita, E., Yamamoto, K. and Sakamoto, H. (1996). Two different RNA
binding activities for the AU-rich element and the poly(A) sequence of the mouse
neuronal protein mHuC. Nucleic Acids Res. 24, 4895-4901.
Akamatsu, W., Okano, H. J., Osumi, N., Inoue, T., Nakamura, S., Sakakibara, S.,
Miura, M., Matsuo, N., Darnell, R. B. and Okano, H. (1999). Mammalian ELAV-
like neuronal RNA-binding proteins HuB and HuC promote neuronal development in
both the central and the peripheral nervous systems. Proc. Natl. Acad. Sci. USA 96,
9885-9890.
Akamatsu, W., Fujihara, H., Mitsuhashi, T., Yano, M., Shibata, S., Hayakawa, Y.,
Okano, H. J., Sakakibara, S., Takano, H., Takano, T. et al. (2005). The RNA-
binding protein HuD regulates neuronal cell identity and maturation. Proc. Natl. Acad.
Sci. USA 102, 4625-4630.
Alvarez-Buylla, A. and Garcia-Verdugo, J. M. (2002). Neurogenesis in adult
subventricular zone. J. Neurosci. 22, 629-634.
Antic, D. and Keene, J. D. (1997). Embryonic lethal abnormal visual RNA-binding
proteins involved in growth, differentiation, and posttranscriptional gene expression.
Am. J. Hum. Genet. 61, 273-278.
Antic, D., Lu, N. and Keene, J. D. (1999). ELAV tumor antigen, Hel-N1, increases
translation of neurofilament M mRNA and induces formation of neurites in human
teratocarcinoma cells. Genes Dev. 13, 449-461.
Aranda-Abreu, G. E., Behar, L., Chung, S., Furneaux, H. and Ginzburg, I. (1999).
Embryonic lethal abnormal vision-like RNA-binding proteins regulate neurite
outgrowth and tau expression in PC12 cells. J. Neurosci. 19, 6907-6917.
Asson-Batres, M. A., Spurgeon, S. L., Diaz, J., DeLoughery, T. G. and Bagby, G. C.,
Jr (1994). Evolutionary conservation of the AU-rich 3 untranslated region of
messenger RNA. Proc. Natl. Acad. Sci. USA 91, 1318-1322.
Bakheet, T., Frevel, M., Williams, B. R., Greer, W. and Khabar, K. S. (2001). ARED:
human AU-rich element-containing mRNA database reveals an unexpectedly diverse
functional repertoire of encoded proteins. Nucleic Acids Res. 29, 246-254.
Barami, K., Iversen, K., Furneaux, H. and Goldman, S. A. (1995). Hu protein as an
early marker of neuronal phenotypic differentiation by subependymal zone cells of the
adult songbird forebrain. J. Neurobiol. 28, 82-101.
Battelli, C., Nikopoulos, G. N., Mitchell, J. G. and Verdi, J. M. (2006). The RNA-
binding protein Musashi-1 regulates neural development through the translational
repression of p21(WAF-1). Mol. Cell Neurosci. 31, 85-96.
Bevilacqua, A., Ceriani, M. C., Capaccioli, S. and Nicolin, A. (2003). Post-
transcriptional regulation of gene expression by degradation of messenger RNAs. J.
Cell. Physiol. 195, 356-372.
Bez, A., Corsini, E., Curti, D., Biggiogera, M., Colombo, A., Nicosia, R. F., Pagano,
S. F. and Parati, E. A. (2003). Neurosphere and neurosphere-forming cells:
morphological and ultrastructural characterization. Brain Res. 993, 18-29.
Bolognani, F., Merhege, M. A., Twiss, J. and Perrone-Bizzozero, N. I. (2004).
Dendritic localization of the RNA-binding protein HuD in hippocampal neurons:
association with polysomes and upregulation during contextual learning. Neurosci.
Lett. 371, 152-157.
Bottai, D., Fiocco, R., Gelain, F., Defilippis, L., Galli, R., Gritti, A. and Vescovi, L.
A. (2003). Neural stem cells in the adult nervous system. J. Hematother. Stem Cell Res.
12, 655-670.
Briata, P., Ilengo, C., Corte, G., Moroni, C., Rosenfeld, M. G., Chen, C. Y. and
Gherzi, R. (2003). The Wnt/beta-catenin–>Pitx2 pathway controls the turnover of
Pitx2 and other unstable mRNAs. Mol. Cell 12, 1201-1211.
Cayouette, M. and Raff, M. (2002). Asymmetric segregation of Numb: a mechanism for
neural specification from Drosophila to mammals. Nat. Neurosci. 5, 1265-1269.
Chakrabarti, S. K., James, J. C. and Mirmira, R. G. (2002). Quantitative assessment
of gene targeting in vitro and in vivo by the pancreatic transcription factor, Pdx1.
Importance of chromatin structure in directing promoter binding. J. Biol. Chem. 277,
13286-13293.
Chen, C. Y. and Shyu, A. B. (1995). AU-rich elements: characterization and importance
in mRNA degradation. Trends Biochem. Sci. 20, 465-470.
Chu, E., Koeller, D. M., Casey, J. L., Drake, J. C., Chabner, B. A., Elwood, P. C.,
Zinn, S. and Allegra, C. J. (1991). Autoregulation of human thymidylate synthase
messenger RNA translation by thymidylate synthase. Proc. Natl. Acad. Sci. USA 88,
8977-8981.
Chung, S., Eckrich, M., Perrone-Bizzozero, N., Kohn, D. T. and Furneaux, H. (1997).
The Elav-like proteins bind to a conserved regulatory element in the 3-untranslated
region of GAP-43 mRNA. J. Biol. Chem. 272, 6593-6598.
Cova, L., Ratti, A., Volta, M., Fogh, I., Cardin, V., Corbo, M. and Silani, V. (2004).
Stem cell therapy for neurodegenerative diseases: the issue of transdifferentiation. Stem
Cells Dev. 13, 121-131.
Cuadrado, A., Garcia-Fernandez, L. F., Imai, T., Okano, H. and Munoz, A. (2002).
Regulation of tau RNA maturation by thyroid hormone is mediated by the neural RNA-
binding protein musashi-1. Mol. Cell. Neurosci. 20, 198-210.
Cuadrado, A., Navarro-Yubero, C., Furneaux, H. and Munoz, A. (2003). Neuronal
HuD gene encoding a mRNA stability regulator is transcriptionally repressed by
thyroid hormone. J. Neurochem. 86, 763-773.
Ding, Y., Chan, C. Y. and Lawrence, C. E. (2004). Sfold web server for statistical
folding and rational design of nucleic acids. Nucleic Acids Res. 32, W135-W141.
Douen, A. G., Dong, L., Vanance, S., Munger, R., Hogan, M. J., Thompson, C. S. and
Hakim, A. M. (2004). Regulation of nestin expression after cortical ablation in adult
rat brain. Brain Res. 1008, 139-146.
Esdar, C., Oehrlein, S. A., Reinhardt, S., Maelicke, A. and Herget, T. (1999). The
protein kinase C (PKC) substrate GAP-43 is already expressed in neural precursor cells,
colocalizes with PKCeta and binds calmodulin. Eur. J. Neurosci. 11, 503-516.
Ford, L. P. and Wilusz, J. (1999). An in vitro system using HeLa cytoplasmic extracts
that reproduces regulated mRNA stability. Methods 17, 21-27.
Ford, L. P., Watson, J., Keene, J. D. and Wilusz, J. (1999). ELAV proteins stabilize
deadenylated intermediates in a novel in vitro mRNA deadenylation/degradation
system. Genes Dev. 13, 188-201.
Galli, R., Gritti, A., Bonfanti, L. and Vescovi, A. L. (2003). Neural stem cells: an
overview. Circ. Res. 92, 598-608.
Gao, F. B., Carson, C. C., Levine, T. and Keene, J. D. (1994). Selection of a subset of
mRNAs from combinatorial 3 untranslated region libraries using neuronal RNA-
binding protein Hel-N1. Proc. Natl. Acad. Sci. USA 91, 11207-11211.
Gritti, A., Frolichsthal-Schoeller, P., Galli, R., Parati, E. A., Cova, L., Pagano, S. F.,
Bjornson, C. R. and Vescovi, A. L. (1999). Epidermal and fibroblast growth factors
behave as mitogenic regulators for a single multipotent stem cell-like population from
the subventricular region of the adult mouse forebrain. J. Neurosci. 19, 3287-3297.
Hitoshi, S., Alexson, T., Tropepe, V., Donoviel, D., Elia, A. J., Nye, J. S., Conlon, R.
A., Mak, T. W., Bernstein, A. and van der Kooy, D. (2002). Notch pathway molecules
are essential for the maintenance, but not the generation, of mammalian neural stem
cells. Genes Dev. 16, 846-858.
Imai, T., Tokunaga, A., Yoshida, T., Hashimoto, M., Mikoshiba, K., Weinmaster, G.,
Nakafuku, M. and Okano, H. (2001). The neural RNA-binding protein Musashi1
translationally regulates mammalian numb gene expression by interacting with its
mRNA. Mol. Cell. Biol. 21, 3888-3900.
Irwin, N., Baekelandt, V., Goritchenko, L. and Benowitz, L. I. (1997). Identification
of two proteins that bind to a pyrimidine-rich sequence in the 3-untranslated region
of GAP-43 mRNA. Nucleic Acids Res. 25, 1281-1288.
Joseph, B., Orlian, M. and Furneaux, H. (1998). p21(waf1) mRNA contains a
conserved element in its 3-untranslated region that is bound by the Elav-like mRNA-
stabilizing proteins. J. Biol. Chem. 273, 20511-20516.
Kaneko, Y., Sakakibara, S., Imai, T., Suzuki, A., Nakamura, Y., Sawamoto, K.,
Ogawa, Y., Toyama, Y., Miyata, T. and Okano, H. (2000). Musashi1: an
evolutionally conserved marker for CNS progenitor cells including neural stem cells.
Dev. Neurosci. 22, 139-153.
Kanemura, Y., Mori, K., Sakakibara, S., Fujikawa, H., Hayashi, H., Nakano, A.,
Matsumoto, T., Tamura, K., Imai, T., Ohnishi, T. et al. (2001). Musashi1, an
evolutionarily conserved neural RNA-binding protein, is a versatile marker of human
glioma cells in determining their cellular origin, malignancy, and proliferative activity.
Differentiation 68, 141-152.
Kasashima, K., Terashima, K., Yamamoto, K., Sakashita, E. and Sakamoto, H.
(1999). Cytoplasmic localization is required for the mammalian ELAV-like protein
HuD to induce neuronal differentiation. Genes Cells 4, 667-683.
Kee, N., Sivalingam, S., Boonstra, R. and Wojtowicz, J. M. (2002). The utility of Ki-
67 and BrdU as proliferative markers of adult neurogenesis. J. Neurosci. Methods 115,
97-105.
Keene, J. D. (2001). Ribonucleoprotein infrastructure regulating the flow of genetic
information between the genome and the proteome. Proc. Natl. Acad. Sci. USA 98,
7018-7024.
Kempermann, G., Jessberger, S., Steiner, B. and Kronenberg, G. (2004). Milestones
of neuronal development in the adult hippocampus. Trends Neurosci. 27, 447-452.
Kohn, D. T., Tsai, K. C., Cansino, V. V., Neve, R. L. and Perrone-Bizzozero, N. I.
Jo
ur
n
a
l o
f C
el
l S
cie
nc
e
(1996). Role of highly conserved pyrimidine-rich sequences in the 3 untranslated
region of the GAP-43 mRNA in mRNA stability and RNA-protein interactions. Brain
Res. Mol. Brain Res. 36, 240-250.
Lakshmipathy, U. and Verfaillie, C. (2005). Stem cell plasticity. Blood Rev. 19, 29-38.
Lal, A., Mazan-Mamczarz, K., Kawai, T., Yang, X., Martindale, J. L. and Gorospe,
M. (2004). Concurrent versus individual binding of HuR and AUF1 to common labile
target mRNAs. EMBO J. 23, 3092-3102.
Levine, T. D., Gao, F., King, P. H., Andrews, L. G. and Keene, J. D. (1993). Hel-N1:
an autoimmune RNA-binding protein with specificity for 3 uridylate-rich untranslated
regions of growth factor mRNAs. Mol. Cell. Biol. 13, 3494-3504.
Marusich, M. F., Furneaux, H. M., Henion, P. D. and Weston, J. A. (1994). Hu
neuronal proteins are expressed in proliferating neurogenic cells. J. Neurobiol. 25, 143-
155.
Maslov, A. Y., Barone, T. A., Plunkett, R. J. and Pruitt, S. C. (2004). Neural stem cell
detection, characterization, and age-related changes in the subventricular zone of mice.
J. Neurosci. 24, 1726-1733.
Mazan-Mamczarz, K., Galban, S., Lopez de Silanes, I., Martindale, J. L., Atasoy, U.,
Keene, J. D. and Gorospe, M. (2003). RNA-binding protein HuR enhances p53
translation in response to ultraviolet light irradiation. Proc. Natl. Acad. Sci. USA 100,
8354-8359.
Metzger, F. and Kapfhammer, J. P. (2003). Protein kinase C: its role in activity-
dependent Purkinje cell dendritic development and plasticity. Cerebellum 2, 206-214.
Morshead, C. M. and van der Kooy, D. (2004). Disguising adult neural stem cells. Curr.
Opin. Neurobiol. 14, 125-131.
Nakamura, M., Okano, H., Blendy, J. A. and Montell, C. (1994). Musashi, a neural
RNA-binding protein required for Drosophila adult external sensory organ
development. Neuron 13, 67-81.
Okano, H. J. and Darnell, R. B. (1997). A hierarchy of Hu RNA binding proteins in
developing and adult neurons. J. Neurosci. 17, 3024-3037.
Okano, H., Imai, T. and Okabe, M. (2002). Musashi: a translational regulator of cell
fate. J. Cell Sci. 115, 1355-1359.
Pascale, A., Fortino, I., Govoni, S., Trabucchi, M., Wetsel, W. C. and Battaini, F.
(1996). Functional impairment in protein kinase C by RACK1 (receptor for activated
C kinase 1) deficiency in aged rat brain cortex. J. Neurochem. 67, 2471-2477.
Pascale, A., Gusev, P. A., Amadio, M., Dottorini, T., Govoni, S., Alkon, D. L. and
Quattrone, A. (2004). Increase of the RNA-binding protein HuD and
posttranscriptional up-regulation of the GAP-43 gene during spatial memory. Proc.
Natl. Acad. Sci. USA 101, 1217-1222.
Pascale, A., Amadio, M., Scapagnini, G., Lanni, C., Racchi, M., Provenzani, A.,
Govoni, S., Alkon, D. L. and Quattrone, A. (2005). Neuronal ELAV proteins enhance
mRNA stability by a PKCalpha-dependent pathway. Proc. Natl. Acad. Sci. USA 102,
12065-12070.
Perrone-Bizzozero, N. and Bolognani, F. (2002). Role of HuD and other RNA-binding
proteins in neural development and plasticity. J. Neurosci. Res. 68, 121-126.
Qian, X., Shen, Q., Goderie, S. K., He, W., Capela, A., Davis, A. A. and Temple, S.
(2000). Timing of CNS cell generation: a programmed sequence of neuron and glial
cell production from isolated murine cortical stem cells. Neuron 28, 69-80.
Quattrone, A., Pascale, A., Nogues, X., Zhao, W., Gusev, P., Pacini, A. and Alkon,
D. L. (2001). Posttranscriptional regulation of gene expression in learning by the
neuronal ELAV-like mRNA-stabilizing proteins. Proc. Natl. Acad. Sci. USA 98,
11668-11673.
Robinow, S. and White, K. (1991). Characterization and spatial distribution of the ELAV
protein during Drosophila melanogaster development. J. Neurobiol. 22, 443-461.
Roegiers, F. and Jan, Y. N. (2004). Asymmetric cell division. Curr. Opin. Cell Biol. 16,
195-205.
Sakakibara, S. and Okano, H. (1997). Expression of neural RNA-binding proteins in
the postnatal CNS: implications of their roles in neuronal and glial cell development.
J. Neurosci. 17, 8300-8312.
Sakakibara, S., Imai, T., Hamaguchi, K., Okabe, M., Aruga, J., Nakajima, K.,
Yasutomi, D., Nagata, T., Kurihara, Y., Uesugi, S. et al. (1996). Mouse-Musashi-1,
a neural RNA-binding protein highly enriched in the mammalian CNS stem cell. Dev.
Biol. 176, 230-242.
Sakakibara, S., Nakamura, Y., Satoh, H. and Okano, H. (2001). Rna-binding protein
Musashi2: developmentally regulated expression in neural precursor cells and
subpopulations of neurons in mammalian CNS. J. Neurosci. 21, 8091-8107.
Samson, M. L. (1998). Evidence for 3 untranslated region-dependent autoregulation of
the Drosophila gene encoding the neuronal nuclear RNA-binding protein ELAV.
Genetics 150, 723-733.
Schaeffer, C., Bardoni, B., Mandel, J. L., Ehresmann, B., Ehresmann, C. and Moine,
H. (2001). The fragile X mental retardation protein binds specifically to its mRNA via
a purine quartet motif. EMBO J. 20, 4803-4813.
Schinder, A. F. and Gage, F. H. (2004). A hypothesis about the role of adult neurogenesis
in hippocampal function. Physiology (Bethesda) 19, 253-261.
Shaw, G. and Kamen, R. (1986). A conserved AU sequence from the 3 untranslated
region of GM-CSF mRNA mediates selective mRNA degradation. Cell 46, 659-667.
Suslov, O. N., Kukekov, V. G., Ignatova, T. N. and Steindler, D. A. (2002). Neural stem
cell heterogeneity demonstrated by molecular phenotyping of clonal neurospheres.
Proc. Natl. Acad. Sci. USA 99, 14506-14511.
Szabo, A., Dalmau, J., Manley, G., Rosenfeld, M., Wong, E., Henson, J., Posner, J.
B. and Furneaux, H. M. (1991). HuD, a paraneoplastic encephalomyelitis antigen,
contains RNA-binding domains and is homologous to Elav and Sex-lethal. Cell 67,
325-333.
Tenenbaum, S. A., Lager, P. J., Carson, C. C. and Keene, J. D. (2002). Ribonomics:
identifying mRNA subsets in mRNP complexes using antibodies to RNA-binding
proteins and genomic arrays. Methods 26, 191-198.
Toda, M., Iizuka, Y., Yu, W., Imai, T., Ikeda, E., Yoshida, K., Kawase, T., Kawakami,
Y., Okano, H. and Uyemura, K. (2001). Expression of the neural RNA-binding
protein Musashi1 in human gliomas. Glia 34, 1-7.
Wakamatsu, Y. and Weston, J. A. (1997). Sequential expression and role of Hu RNA-
binding proteins during neurogenesis. Development 124, 3449-3460.
Wiese, C., Rolletschek, A., Kania, G., Blyszczuk, P., Tarasov, K. V., Tarasova, Y.,
Wersto, R. P., Boheler, K. R. and Wobus, A. M. (2004). Nestin expression–a property
of multi-lineage progenitor cells? Cell. Mol. Life Sci. 61, 2510-2522.
Yagita, Y., Kitagawa, K., Sasaki, T., Miyata, T., Okano, H., Hori, M. and Matsumoto,
M. (2002). Differential expression of Musashi1 and nestin in the adult rat hippocampus
after ischemia. J. Neurosci. Res. 69, 750-756.
Yano, M., Okano, H. J. and Okano, H. (2005). Involvement of Hu and heterogeneous
nuclear ribonucleoprotein K in neuronal differentiation through p21 mRNA post-
transcriptional regulation. J. Biol. Chem. 280, 12690-12699.
Zhong, W., Feder, J. N., Jiang, M. M., Jan, L. Y. and Jan, Y. N. (1996). Asymmetric
localization of a mammalian numb homolog during mouse cortical neurogenesis.
Neuron 17, 43-53.
Journal of Cell Science 119 (7)1452
Jo
ur
n
a
l o
f C
el
l S
cie
nc
e
1Accepted 21 December 2005
Journal of Cell Science 119, 1442-1452 Published by The Company of Biologists 2006
doi:10.1242/jcs.02852
Supplementary Tables
Table S1. Real-time PCR data
Gene Sample Mean Ct ΔCt ΔΔCt Fold Difference (2-ΔΔCt) s.e.m.
Input_nELAV 18.8
IP_nELAV 27.4
8.6 -1.7 3.2 1.7
Input_His5 18.6
IP_His5 27.8
9.2 -0.9 1.9 0.6
Input_noAb 19.2
Rpl10a
IP_noAb 29.5
10.3 0 1.0 0
Input_nELAV 25.9
IP_nELAV 27.6
1.7 -6.0 64 7.9
Input_His5 25.4
IP_His5 32.2
6.7 -1.0 2.0 2.5
Input_noAb 26.4
Msi-1
IP_noAb 34.1
7.7 0 1.0 0
Input_nELAV 22.3
IP_nELAV 29.3
7.1 -1.1 2.1 0.8
Input_His5 21.9
IP_His5 29.7
7.8 -0.4 1.3 0.9
Input_noAb 22.8
GAP-43
IP_noAb 31
8.2 0 1.0 0
Input_nELAV 27
IP_nELAV 35.1
9.0 -2.0 4.0 1.4
Input_His5 26
IP_His5 35.9
9.9 -1.1 2.1 3.0
Input_noAb 27.1
Tau
IP_noAb 38.1
11 0 1 0
Table S2. Antibody dilutions in ICC and IHC assays
Table S3. Primer sequences for real-time PCR
Musashi-1 Polyclonal Chemicon 1:100 for ICC and 1:150 for IHC
nELAV (16A11) Monoclonal Molecular Probes 1:100 for ICC and 1:200 for IHC
Ki67 Polyclonal NovoCastra 1:500 for ICC and 1:600 for IHC
Nestin Monoclonal/Polyclonal Chemicon 1:200 for ICC
Secondary antibody Cy2 Monoclonal/Polyclonal Jackson ImmunoRes. Lab. 1:500 for ICC and IHC
Secondary antibody Cy3 Monoclonal/Polyclonal Jackson ImmunoRes. Lab. 1:500 for ICC and IHC
2Msi-1_fw TGCAGCTGACTGAGGACCAGA
Msi-1_rev GGTGTCCCAATCCCCT
GAP-43_fw AGGCTGACCAAGAACATGCCT
GAP-43_rev GGCAACGTGGAAAGCCATTT
Rpl10a_fw GAAGAAGGTGCTGTGTTTGGC
Rpl10a_rev TCGGTCATCTTCACGTGGC
Tau_for TCCCTGGAGGAGGGAATAAGA
Tau_rev CCCTGAAGGTCAGCTTGTGG
